Cryosurgery in difficult to treat basal cell carcinoma

Jaramillo-Ayerbe, Felipe

doi:10.1046/j.1365-4362.2000.00952.x

Cited by 36 publications

(20 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Wounds usually heal with good cosmetic results, although two cycles of 20 seconds freeze and 60 seconds thaw are associated with significantly worse cosmetic outcome than standard surgical excision for superficial and nodular BCCs of the head and neck [95]. Recurrence rates vary greatly (8-40%), but in selected lesions and in expert hands, they may be as low as 1% [96][97][98][99].…”

Section: Cryosurgerymentioning

confidence: 99%

Update of the European guidelines for basal cell carcinoma management

Trakatelli¹,

Morton²,

Nagore³

et al. 2014

European Journal of Dermatology

204

197

View full text Add to dashboard Cite

Background European guidelines for the management of basal cell carcinoma (BCC) prepared by the former BCC subcommittee of the Guidelines Committee of the European Dermatology Forum (EDF) were published in 2006. Objectives To present updated guidelines that include consensual expert definitions on various BCC types, prognosis and risk factors for BCC as well as review recommendations for diagnosis and treatment reflecting current published evidence. Methods These guidelines (S1 type) were prepared by the new BCC subgroup of the European Dermatology Forum (EDF)'s Guidelines Committee through extensive literature review (up to 2012) and expert experience; they were extensively discussed within the EDF subcommittee and approved by peer reviewers of the EDF. Results BCC is a common tumour with an incidence rising worldwide. Three major clinical types of BCC are recognized: nodular, superficial and morpheaform. Four histological subtypes are defined: superficial, nodular, infiltrative and morpheaform. On the basis of the risk of relapse, three prognosis groups have been identified: high, intermediate and low risk. According to these classifications and evidence-based evaluation of the therapeutic strategies available, a decision tree is proposed for the management of BCCs. Conclusions. The guidelines offer a useful tool that will help dermatologists to select the most appropriate treatment for individual patients.

show abstract

Section: Cryosurgerymentioning

confidence: 99%

Update of the European guidelines for basal cell carcinoma management

Trakatelli¹,

Morton²,

Nagore³

et al. 2014

European Journal of Dermatology

204

197

View full text Add to dashboard Cite

show abstract

“…In expert hands, cryosurgery also has a role in the management of high‐risk lesions, either as the sole treatment 118 or following curettage 108,119 . A follow‐up study of 171 high‐risk BCCs treated with combined curettage/cryotherapy reported a 8% recurrence rate after a mean follow up of 5·2 years (range 6 months–9·1 years) 119 . Although cryosurgery is less useful for the treatment of recurrent BCC, 59 selected lesions may also respond to aggressive expert treatment 120 …”

Section: Destructive Techniques: Surgicalmentioning

confidence: 99%

Guidelines for the management of basal cell carcinoma

Telfer¹,

Colver²,

Morton³

2008

Br J Dermatol

735

452

View full text Add to dashboard Cite

Summary This article represents a planned regular updating of the previous British Association of Dermatologists guidelines for the management of basal cell carcinoma. These guidelines present evidence‐based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.

show abstract

“…Rare complications include delayed bleeding, infection, syncope, pyogenic granuloma, and hypertrophic scarring 16,17 . Cosmetic results have been qualitatively described as good in literature 4,7–13 . The Thissen et al study focused on cosmetic aspect of cryosurgery in treatment of BCC as compared with excision surgery.…”

Section: Resultsmentioning

confidence: 99%

Evidence-Based Review of the Use of Cryosurgery in Treatment of Basal Cell Carcinoma

Kokoszka

Scheinfeld

2003

Dermatol Surg

View full text Add to dashboard Cite

According to the best evidence, recurrence rates of BCC treated with cryosurgery are low (less than 10%). Except in one study, recurrence rates are calculated based on clinical, rather than histologic diagnosis, which may cause the rates to appear somewhat lower than they actually are, especially with a short follow-up period. Cosmetic results of cryosurgery treatment reported in literature are described as good by most investigators. Overall, there are sufficient data to consider cryosurgery as a reasonable treatment for BCC. There are no good studies, however, comparing cryosurgery with other modalities, particularly with Mohs surgery, excision, or electrodessication and curretage so that no conclusion can be made whether cryosurgery is as efficacious as other methods. Also, there is no evidence on whether curetting the lesions before cryosurgery affects the efficacy of treatment.

show abstract

Cryosurgery in difficult to treat basal cell carcinoma

Abstract: Cryosurgery is a well-tolerated therapeutic modality that offers an acceptable cure rate and good functional and cosmetic results in difficult to treat BCC.

Cited by 36 publications

References 25 publications

Update of the European guidelines for basal cell carcinoma management

Update of the European guidelines for basal cell carcinoma management

Guidelines for the management of basal cell carcinoma

Evidence-Based Review of the Use of Cryosurgery in Treatment of Basal Cell Carcinoma

Contact Info

Product

Resources

About